Transfer Pricing
August 11, 2025
Empowering Vaccine Manufacturers for Global Health Equity
We're excited to share our latest whitepaper, which dives into the production economics of vaccine manufacturing, offering actionable insights for new and existing manufacturers, especially in low- and middle-income countries (LMICs). This piece was co-authored with the Clinton Health Access Initiative (CHAI) and BDO and made possible by the Gates Foundation.
Our analysis highlights key factors influencing production costs and profitability, providing insight for sustainable, cost-effective operations. Key takeaways include the importance of scale, securing demand commitments and leveraging innovation.
Explore how these insights can transform new manufacturers into competitive players in the international vaccine landscape, contributing to global health equity and resilience.
Read the full whitepaper to learn more!
Stay Ahead with Kroll
Valuation Services
When companies require an objective and independent assessment of value, they look to Kroll.
Transfer Pricing
Kroll's team of internationally recognized transfer pricing advisors provide the technical expertise and industry experience necessary to ensure understandable, implementable and supportable results.
Trade and Customs
Kroll helps clients proactively develop strategies, manage risks, uncover and address compliance gaps, and respond to investigations or enforcement actions across the full spectrum of trade and customs challenges.
